A clinical study to evaluate the effects of a Unani herbal formulation on Polycystic Ovarian Disease (PCOD)

Unani Perspective on Akyaas-e-khusyat ur reham (PCOD): A Classical Insight with Herbal Emmenagogue Formulation

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106462

Enrollment

Registered

2026-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N839- Noninflammatory disorder of ovary,fallopian tube and broad ligament, unspecified

Interventions

Intervention1: Unani herbal formulation: An oral Unani herbal formulation consisting of Abhal (Juniperus communis), Asaroon (Asarum europaeum), Izkhir (Cymbopogon jwarancusa), and Anjra (Blepharis edu

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with PCOD based on Rotterdam Criteria History of Oligomenorrhea Findings of Polycystic ovaries on ultrasound BMI less than or equal to 30 Willing to participate and give informed consent

Exclusion criteria

Exclusion criteria: Pregnancy or lactation History of pelvic surgery or endometriosis. Use of hormonal treatment in past 2 months. Renal or hepatic dysfunction. Allergies to trial drug

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of the Unani herbal combination on menstrual regularityTimepoint: Baseline (Day 0) and post-trial (12 weeks)	—

Secondary

Measure	Time frame
Reduction in cystic morphology on ultrasonography (USG) of the ovariesTimepoint: Baseline (Day 0) and post-trial (12 weeks)	—

Countries

India

Contacts

Public ContactDr Mubasheera Begum

Government Unani Medical College, Chennai

sayeedazubyr@gmail.com08610295864

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026